The Core Benefits of Microdosing Liver and Cardiovascular Protection A 72-week trial found 40% of patients achieved resolution of fatty liver disease without worsening fibrosis. In animal models, GLP-1s suppress fat production in the liver and reduce inflammation. Tirzepatide at low doses showed particularly strong cardiovascular benefits, with meaningful improvements across multiple lipid markers linked to heart disease risk. Cholesterol storage forms increased far less with tirzepatide, and harmful lipids like ceramides showed minimal increase compared to placebo
When you use our products, you can be confident that your timeline is being dictated by biology, not by poor manufacturing
Double-checking prevents errors that compound over weeks of dosing
Semaglutide preserves mitochondrial structure and function under chronic stress
Magnesium citrate is an alternative that also helps with constipation , which can be a useful secondary benefit
For Orange County patients, the appeal of Ozempic often comes down to practicality